Apple Earnings Just Dropped | Here's What You Need to Know
In a Nutshell
Apple reported stellar Q2 earnings with $111B revenue (2.1% beat), $2.01 EPS (massive beat), 49% gross margins, and beats across all segments except a slight iPhone miss due to supply constraints amid strong demand. Highlights include $100B buyback authorization, robust Greater China growth to $20.5B, upcoming iPhone 17 with advanced TSMC chips, MacBook Neo targeting budget market, and leadership transition to John Ternus in September. Stock hit near all-time highs at $284.60 (P/E 33.8, $4T market cap), performing well without heavy AI hype; a solid hold but overextended short-term—buy on pullbacks.
These notes were generated by AI and may contain inaccuracies.
Favorite part about Apple reporting earnings: wasn't flooded with the word AI. Apple isn't the sexiest of the Magnificent Companies because it doesn't slap AI in headlines. Apple reported one of its best earnings ever, up 2% after guidance call, at one point up almost 5%, hit 4%. Nasdaq still holding green.
Goal: share biggest takeaways from Apple earnings and call to learn something new. Apple nearly broke all-time highs, trading at highs of 284.60, previous highs 288. Not a really good deal at these levels short term, still overextended. If markets pull back, Apple likely to pull back. If already invested (speaker's entry in the hundreds), no intention of selling on 5% move up or down.
Better than expected EPS ($2.01 vs expectation ~$0.98-$0.99) and revenue (2.1% beat). Q2 revenue $111 billion vs expectation $109 billion. EPS beat. Gross margin 49% vs expectation 48%. Dividends 27 cents per share.
- iPhone revenue: $56.99 billion (miss vs $57.2 billion expectation)
- Services revenue: $30.98 billion vs $30.39 billion
- Mac revenue: $8.4 billion vs $8.02 billion
- Wearables revenue: $7.9 billion vs $7.7 billion
- iPad revenue: $6.91 billion vs $6.66 billion
- Greater China revenue: $20.5 billion vs $19.5 billion
Sign in to read the full notes
Get access to AI-generated notes, topic timestamps, and more.